Table S4.
MFI signal and ICC for CV autoantibodies in 65 participants
| MFI signal | ICC, % | PICC | ||
| Autoantibodies | Baseline | Follow-up | ||
| Troponin I | 5,689 (2,018–16,482) | 5,702 (1,901–15,849) | 99.7 | <0.0001 |
| Annexin-A5 | 1,161 (376–3,206) | 1,145 (383–3,148) | 99.5 | <0.0001 |
| ADRBK1 | 1,770 (798–3,990) | 1,738 (793–3,767) | 99.4 | <0.0001 |
| CHRM2 | 3,873 (1,435–9,078) | 3,855 (1,445–8,954) | 99.6 | <0.0001 |
| MYH7 | 1,710 (302–7,112) | 1,633 (282–6,855) | 98.7 | <0.0001 |
| MYH6 | 2,213 (794–6,252) | 2,178 (794–6,457) | 99.6 | <0.0001 |
| Titin | 824 (274–2,576) | 859 (267–2,455) | 93.7 | <0.0001 |
| EDNR-A | 1,330 (357–3,837) | 1,312 (331–3,776) | 99.4 | <0.0001 |
| EDNR-B | 1,330 (357–3,837) | 1,312 (331–3,776) | 99.4 | <0.0001 |
| AGTR1 | 1,178 (339–3,214) | 1,180 (325–3,388) | 99.6 | <0.0001 |
MFI values are geometric mean (10–90% interval). Each pair of baseline and follow-up samples was tested side-by-side on the same chip simultaneously; therefore, the interchip variation was not reflected in the analysis of temporal variability results.